{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T16:40:27Z","timestamp":1747154427103,"version":"3.40.5"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Cardiovascular Diseases"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.acvd.2024.02.012","type":"journal-article","created":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T20:07:13Z","timestamp":1712952433000},"page":"351-357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Acute coronary syndrome in patients treated by vitamin K antagonists or non-vitamin K antagonist oral anticoagulants: Proposed management algorithm for the first 48 hours"],"prefix":"10.1016","volume":"117","author":[{"given":"Alexandre","family":"Salaun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"de Maistre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7000-9338","authenticated-orcid":false,"given":"Marl\u00e8ne","family":"Daller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chan","family":"Sombrun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4841-3253","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9ric","family":"Chagu\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3066-118X","authenticated-orcid":false,"given":"Florence","family":"Bichat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Rochette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Danchin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9267-1658","authenticated-orcid":false,"given":"Laurent","family":"Fauchier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Zeller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5176-5121","authenticated-orcid":false,"given":"Yves","family":"Cottin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acvd.2024.02.012_bib0220","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1093\/eurheartj\/eht557","article-title":"Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry","volume":"35","author":"Beyer-Westendorf","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2024.02.012_bib0225","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2024.02.012_bib0230","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1708454","article-title":"Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation","volume":"377","author":"Cannon","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2024.02.012_bib0235","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJMoa1706443","article-title":"Bivalirudin versus heparin monotherapy in myocardial infarction","volume":"377","author":"Erlinge","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2024.02.012_bib0240","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1001\/jama.2015.2323","article-title":"Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial","volume":"313","author":"Han","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.acvd.2024.02.012_bib0245","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1001\/jama.2010.1320","article-title":"Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: the FUTURA\/OASIS-8 randomized trial","volume":"304","author":"Steg","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.acvd.2024.02.012_bib0250","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"72","author":"Thygesen","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2024.02.012_bib0255","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.114.011201","article-title":"Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries","volume":"131","author":"Pasupathy","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2024.02.012_bib0260","doi-asserted-by":"crossref","first-page":"e891","DOI":"10.1161\/CIR.0000000000000670","article-title":"Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the American Heart Association","volume":"139","author":"Tamis-Holland","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2024.02.012_bib0265","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1161\/CIRCULATIONAHA.119.042157","article-title":"A proposal for modest revision of the definition of type 1 and type 2 myocardial infarction","volume":"140","author":"de Lemos","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2024.02.012_bib0270","doi-asserted-by":"crossref","first-page":"e005587","DOI":"10.1161\/CIRCINTERVENTIONS.117.005587","article-title":"Coronary embolism among ST-segment-elevation myocardial infarction patients: mechanisms and management","volume":"11","author":"Popovic","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.acvd.2024.02.012_bib0275","doi-asserted-by":"crossref","first-page":"155","DOI":"10.7326\/0003-4819-88-2-155","article-title":"Coronary artery embolism and myocardial infarction","volume":"88","author":"Prizel","year":"1978","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.acvd.2024.02.012_bib0280","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/CIRCULATIONAHA.114.015134","article-title":"Prevalence, clinical features, and prognosis of acute myocardial infarction attributable to coronary artery embolism","volume":"132","author":"Shibata","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2024.02.012_bib0285","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.avsg.2020.10.031","article-title":"Aortic thrombus in a nonaneurysmal ascending aorta","volume":"72","author":"Chen","year":"2021","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.acvd.2024.02.012_bib0290","first-page":"779","article-title":"Ischemic stroke with cardiac involvement in aortic thromboembolism","volume":"54","author":"Colombo","year":"2006","journal-title":"Minerva Cardioangiol"},{"key":"10.1016\/j.acvd.2024.02.012_bib0295","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.avsg.2012.03.011","article-title":"Aortic mural thrombus in the normal or minimally atherosclerotic aorta","volume":"27","author":"Fayad","year":"2013","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.acvd.2024.02.012_bib0300","article-title":"Hyperacute simultaneous cardiocerebral infarction related to floating thrombus in the ascending aorta: a case report","volume":"5","author":"Issa","year":"2021","journal-title":"Eur Heart J Case Rep"},{"key":"10.1016\/j.acvd.2024.02.012_bib0305","first-page":"105","article-title":"[Myocardial infarction associated with stroke revealing a thrombus of the ascending aorta]","volume":"53","author":"Jaafari","year":"2004","journal-title":"Ann Cardiol Angeiol (Paris)"},{"key":"10.1016\/j.acvd.2024.02.012_bib0310","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.tcm.2022.07.004","article-title":"Coronary artery embolism and acute coronary syndrome: a critical appraisal of existing data","volume":"34","author":"Monin","year":"2024","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.acvd.2024.02.012_bib0315","doi-asserted-by":"crossref","first-page":"e0267","DOI":"10.1097\/XCE.0000000000000267","article-title":"Preexisting atrial fibrillation and myocardial infarction: only 10% of infarcts directly linked to atrial fibrillation","volume":"11","author":"Putot","year":"2022","journal-title":"Cardiovasc Endocrinol Metab"},{"key":"10.1016\/j.acvd.2024.02.012_bib0320","first-page":"581","article-title":"A Concurrent ischemic stroke, myocardial infarction, and aortic thrombi in a young patient with hyperhomocysteinemia: a case report","volume":"13","author":"Rawashdeh","year":"2020","journal-title":"Int Med Case Rep J"},{"key":"10.1016\/j.acvd.2024.02.012_bib0325","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.jacc.2017.07.784","article-title":"The many faces of type 2 myocardial infarction","volume":"70","author":"Januzzi","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2024.02.012_bib0330","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2024.02.012_bib0335","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/ALN.0000000000001631","article-title":"Management of severe bleeding in patients treated with direct oral anticoagulants: an observational registry analysis","volume":"127","author":"Albaladejo","year":"2017","journal-title":"Anesthesiology"},{"key":"10.1016\/j.acvd.2024.02.012_bib0340","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.thromres.2022.06.005","article-title":"Management of urgent invasive procedures in patients treated with direct oral anticoagulants: an observational registry analysis","volume":"216","author":"Godon","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.acvd.2024.02.012_bib0345","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1161\/CIRCULATIONAHA.117.031806","article-title":"Long-term outcomes in patients with type 2 myocardial infarction and myocardial injury","volume":"137","author":"Chapman","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2024.02.012_bib0350","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/bjh.13810","article-title":"Laboratory measurement of the direct oral anticoagulants","volume":"172","author":"Dale","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.acvd.2024.02.012_bib0355","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","article-title":"Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial","volume":"381","author":"Dewilde","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.acvd.2024.02.012_bib0360","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/jth.13912","article-title":"Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians","volume":"16","author":"Douxfils","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.acvd.2024.02.012_bib0365","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1001\/jamacardio.2017.0364","article-title":"Laboratory monitoring of non-vitamin k antagonist oral anticoagulant use in patients with atrial fibrillation: a review","volume":"2","author":"Eikelboom","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.acvd.2024.02.012_bib0370","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1093\/eurheartj\/ehz732","volume":"40","author":"Gargiulo","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2024.02.012_bib0375","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1056\/NEJMoa1611594","article-title":"Prevention of bleeding in patients with atrial fibrillation undergoing PCI","volume":"375","author":"Gibson","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2024.02.012_bib0380","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1817083","article-title":"Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation","volume":"380","author":"Lopes","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2024.02.012_bib0385","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.chest.2016.08.1462","article-title":"Laboratory Assessment of the anticoagulant activity of direct oral anticoagulants: a systematic review","volume":"151","author":"Samuelson","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.acvd.2024.02.012_bib0390","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0140-6736(19)31872-0","article-title":"Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial","volume":"394","author":"Vranckx","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.acvd.2024.02.012_bib0395","doi-asserted-by":"crossref","first-page":"I","DOI":"10.1177\/2396987321989865","article-title":"European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke","volume":"6","author":"Berge","year":"2021","journal-title":"Eur Stroke J"},{"key":"10.1016\/j.acvd.2024.02.012_bib0400","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1177\/2396987319849763","article-title":"European Stroke Organisation guideline on reversal of oral anticoagulants in acute intracerebral haemorrhage","volume":"4","author":"Christensen","year":"2019","journal-title":"Eur Stroke J"},{"key":"10.1016\/j.acvd.2024.02.012_bib0405","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/23969873211050848","article-title":"Intravenous thrombolysis in patients taking direct oral anticoagulants (ESO IVT guidelines comment)","volume":"6","author":"Seiffge","year":"2021","journal-title":"Eur Stroke J"},{"key":"10.1016\/j.acvd.2024.02.012_bib0410","doi-asserted-by":"crossref","first-page":"347","DOI":"10.5853\/jos.2017.00395","article-title":"Intravenous thrombolysis in patients with stroke taking rivaroxaban using drug specific plasma levels: experience with a standard operation procedure in clinical practice","volume":"19","author":"Seiffge","year":"2017","journal-title":"J Stroke"},{"key":"10.1016\/j.acvd.2024.02.012_bib0415","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/ene.13582","article-title":"Intravenous thrombolysis for acute ischaemic stroke in patients on direct oral anticoagulants","volume":"25","author":"Touze","year":"2018","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.acvd.2024.02.012_bib0420","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/eurheartj\/ehn441","article-title":"Spontaneous coronary artery dissection: diagnosis by optical coherence tomography","volume":"30","author":"Alfonso","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2024.02.012_bib0425","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1161\/CIRCULATIONAHA.113.001943","article-title":"Inherited and secondary thrombophilia","volume":"129","author":"Cohoon","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2024.02.012_bib0430","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jjcc.2021.01.001","article-title":"Myocardial infarction with non-obstructive coronary arteries (MINOCA): Intracoronary imaging-based diagnosis and management","volume":"77","author":"Sucato","year":"2021","journal-title":"J Cardiol"}],"container-title":["Archives of Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213624000585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213624000585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T14:03:43Z","timestamp":1746108223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875213624000585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1875213624000585"],"URL":"https:\/\/doi.org\/10.1016\/j.acvd.2024.02.012","relation":{},"ISSN":["1875-2136"],"issn-type":[{"type":"print","value":"1875-2136"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute coronary syndrome in patients treated by vitamin K antagonists or non-vitamin K antagonist oral anticoagulants: Proposed management algorithm for the first 48hours","name":"articletitle","label":"Article Title"},{"value":"Archives of Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acvd.2024.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}